Sequence length required for homologous recombination in Cryptococcus neoformans

Fungal Genetics and Biology

Volumn 38, Issue 1, 2003, Pages 1-9

  Nelson, Rex T ^a   Pryor, Bryant A ^a   Lodge, Jennifer K ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gene disruption; Genetics; Pathogenesis; Virulence

Indexed keywords

FUNGAL DNA; HYGROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DNA FLANKING REGION; DNA SEQUENCE; DNA VECTOR; FUNGAL GENE; GENE CONSTRUCT; GENE DISRUPTION; GENE LOCUS; GENE TARGETING; HOMOLOGOUS RECOMBINATION; MARKER GENE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIRULENCE;

BLOTTING, SOUTHERN; CRYPTOCOCCUS NEOFORMANS; DNA, FUNGAL; MUTAGENESIS, INSERTIONAL; PLASMIDS; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; TRANSFORMATION, GENETIC; VIRULENCE;

CRYPTOCOCCUS NEOFORMANS VAR. GRUBII; FILOBASIDIELLA NEOFORMANS;

EID: 0037331111     PISSN: 10871845     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1087-1845(02)00510-8     Document Type: Article

References (35)

1. Alspaugh J.A., Cavallo L.M., Perfect J.R., Heitman J. RAS1 regulates filamentation, mating and growth at high temperatures in Cryptococcus neoformans. Mol. Cell. Biol. 36:2000;352-365.
2. Casadevall A., Perfect J. Cryptococcus neoformans:1998;ASM Press, Washington, DC.
3. Chang Y., Penoyer L., Kwon-Chung K.J. The second capsule gene of Cryptococcus neoformans CAP64 is essential for virulence. Infect. Immun. 64:1996;1977-1983.
4. Chang Y.C., Kwon-Chung K.J. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol. Cell. Biol. 14:1994;4912-4919.
5. Chang Y.C., Kwon-Chung K.J. Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans. Infect. Immun. 66:1998;2230-2236.
6. Chang Y.C., Kwon-Chung K.J. Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans. J. Bacteriol. 181:1999;5636-5643.
7. Chang Y.C., Wickes B.L., Miller G.F., Penoyer L.A., Kwon-chung K.J. Cryptococcus neoformans STE12. α regulates virulence but is not essential for mating J. Exp. Med. 191:2000;871-881.
8. Cherniak R., Sundstrom J.B. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect. Immun. 62:1994;1507-1512.
9. Cox G.M., McDade H.C., Chen S.C., Tucker S.C., Gottfredsson M., Wright L.C., Sorrell T.C., Leidich S.D., Casadevall A., Ghannoum M.A., Perfect J.R. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol. Microbiol. 39:2001;166-175.
10. Cox G.M., Mukherjee J., Cole G.T., Casadevall A., Perfect J.R. Urease as a virulence factor in experimental cryptococcosis. Infect. Immun. 68:2000;443-448.
11. Cruz M.C., Cavallo L.M., Gorlach J.M., Cox G., Perfect J.R., Cardenas M.E., Heitman J. Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans. Mol. Cell. Biol. 19:1999;4101-4112.
12. Currie B.P., Casadevall A. Estimation of the prevalence of Cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin. Infect. Dis. 19:1994;1029-1033.
13. Davidson R.C., Cruz M.C., Sia R.A., Allen B., Alspaugh J.A., Heitman J. Gene disruption by biolistic transformation in serotype D strains of Cryptococcus neoformans. Fungal Genet. Biol. 29:2000;38-48.
14. Davidson R.C., Moore T.D.E., Odom A.R., Heitman J. Characterization of the MF. α pheromone of the human fungal pathogen Cryptococcus neoformans Mol. Microbiol. 38:2000;1017-1026.
15. Davidson R.C., Blankenship J.R., Kraus P.R., Berrios M.D.J., Hull C.M., D'Souza C., Wang P., Heitman J. A PCR-based strategy to generate integrative targeting alleles with large regions of homology. Microbiology. 148:2002;2607-2615.
16. Dismukes W.E. Cryptococcal Meningitis in patients with AIDS. J. Infect. Dis. 157:1988;859-860.
17. Edman J.C., Kwon-Chung K.J. Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Mol. Cell. Biol. 10:1990;4538-4544.
18. Eng R.H.K., Bishburg E., Smith S.M., Kapila R. Cryptococcal infections in patients with acquired immune deficiency syndrome. Am. J. Med. 81:1986;19-23.
19. Fox D.S., Cruz M.C., Sia R.A.L., Ke H., Cox G.M., Cardenas M.E., Heitman J. Calcinurin regulatory subunit is essential for virulence and mediates interactions with FKBP12-FK506 in Cryptococcus neoformans. Mol. Microbol. 39:2001;835-849.
20. Fromtling R.A., Shadomy H.J., Jacobson E.S. Decreased virulence in stable, acapsular mutants of Cryptococcus neoformans. Mycopathologia. 79:1982;23-29.
21. Goryshin I.Y., Reznikoff W.S. Tn5 in vitro transposition. J. Biol. Chem. 273:1998;7367-7374.
22. Hua J.H., Meyer J.D., Lodge J.K. Development of positive selectable markers for the fungal pathogen, Cryptococcus neoformans. Clin. Diagn. Lab. Immunol. 7:2000;125-128.
23. Jacobson E.S., Goodner A.P., Nyhus K.J. Ferrous iron uptake in Cryptococcus neoformans. Infect. Immun. 66:1998;4169-4175.
24. Kwon-Chung K.J., Rhodes J.C. Ecapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect. Immun. 51:1986;218-223.
25. Lodge J.K., Jackson-Machelski E., Toffaletti D.L., Perfect J.R., Gordon J.I. Targeted gene replacement demonstrates that myristoyl-CoA:protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans. Proc. Natl. Acad. Sci. USA. 91:1994;12008-12012.
26. Lodge J.K., Jackson-Machelski E., Higgins M., McWherter C.A., Sikorski J.A., Devadas B., Gordon J.I. Genetic and biochemical studies establish that the fungicidal effect of a fully depeptidized inhibitor of Cryptococcus neoformans myristoyl-CoA:protein N-myristoyltransferase (Nmt) is Nmt-dependent. J. Biol. Chem. 273:1998;12482-12491.
27. Nelson R.T., Hua J.H., Pryor B.A., Lodge J.K. Identification of virulence mutants in the fungal pathogen Cryptococcus neoformans using signature tagged mutagenesis. Genetics. 157:2001;935-947.
28. Odom A., Muir S., Lim E., Toffaletti D.L., Perfect J.R., Heitman J. Calcinuerin is required for virulence of Cryptococcus neoformans. EMBO J. 16:1997;2576-2589.
29. Salas S.D., Bennett J.E., Kwon-Chung K.J., Perfect J.R., Williamson P.R. Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J. Exp. Med. 184:1996;377-386.
30. Shaw C.E., Kapica L. Production of diagnostic pigment by phenoloxidase activity of Cryptococcus neoformans. Appl. Microbiol. 24:1972;824-830.
31. Toffaletti D.L., Rude T.H., Johnston S.A., Durack D.T., Perfect J.R. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J. Bacteriol. 175:1993;1405-1411.
32. Wang P., Perfect J.R., Heitman J. The G-protein. β subunit GPB1 is required for mating and haploid fruiting in Cryptococcus neoformans Mol. Cell. Biol. 20:2000;352-362.
33. Wang Y., Casadevall A. Growth of Cryptococcus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B. Antimicrob. Agents Chemother. 38:1994;2648-2650.
34. Williamson P.R. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J. Bacteriol. 176:1994;656-664.
35. Yue C., Cavallo L.M., Alspaugh J.A., Wang P., Cox G.M., Perfect J.R., Heitman J. The STE12. α homolog is required for filamentation but largely dispensable for mating and virulence in Cryptococcus neoformans Genetics. 153:1999;1601-1615.